Sify Technologies Limited announced that Dr. S K Rao, an Independent Director of the company, a member of the Audit Committee, Compensation Committee and Nominating Committee has resigned from Board on June 4, 2018 due to health conditions. As a result of Dr. Rao’s resignation, the company is currently not compliant with NASDAQ Listing Rule 5605(b), which requires a majority of the Board of Directors to be comprised of independent directors, and Rule 5605(c)(2), which requires a company to have an Audit Committee comprised of at least three independent directors. The company intends to regain compliance by adding a new independent director before the end of the cure period allowed under NASDAQ rules. Dr. S K Rao’s position on the Board, Audit Committee, Compensation Committee and Nominating Committee will remain vacant till the vacancy is filled up.